Outcomes of refractory or relapsed Hodgkin lymphoma patients with post autologous stem cell transplantation brentuximab vedotin maintenance : a French multicenter observational cohort study - Université de Lorraine Access content directly
Journal Articles Haematologica Year : 2022

Outcomes of refractory or relapsed Hodgkin lymphoma patients with post autologous stem cell transplantation brentuximab vedotin maintenance : a French multicenter observational cohort study

Mohammad Hammoud
Benedicte Deau
  • Function : Correspondent author
  • PersonId : 1131514

Connectez-vous pour contacter l'auteur

Abstract

Not available.
Fichier principal
Vignette du fichier
HAEMATOL-2021-279564v3-Deau[47223].pdf (1.59 Mo) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-03628340 , version 1 (01-04-2022)

Identifiers

Cite

Amira Marouf, Anne Segolene Cottereau, Salim Kanoun, Paul Deschamps, Michel Meignan, et al.. Outcomes of refractory or relapsed Hodgkin lymphoma patients with post autologous stem cell transplantation brentuximab vedotin maintenance : a French multicenter observational cohort study. Haematologica, 2022, 107 (7), pp.1681-1686. ⟨10.3324/haematol.2021.279564⟩. ⟨hal-03628340⟩
73 View
76 Download

Altmetric

Share

Gmail Facebook X LinkedIn More